REG - Northern Trust Corp AbbVie Inc. Allergan PLC - Form 8.3 - Allergan PLC
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1)
Northern Trust Corporation
Company dealt in
Allergan PLC
Class of relevant security to which the dealings being disclosed relate (Note 2)
Common Stock USD 0.0033
Date of dealing
11th May 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Long
Short
Number
(%)
Number
(%)
(1) Relevant securities
29,671,726 9.05%
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
29,671,726 9.05%
Note: The difference in holdings from yesterday and today not explained by transactions, can be explained by stock transfers of 26,002,556 securities into the relevant accounts and 54,154 securities out of the relevant accounts.
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security:
Long
Short
Number
(%)
Number
(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale
Number of relevant securities
Price per unit ($)
SELL
192.88
100
SELL
48265.72
100
BUY
193.84
100
SELL
193.84
100
BUY
96725.27
100
SELL
96725.27
100
BUY
3289240.68
100
SELL
3289240.68
100
BUY
71526.3
100
SELL
71526.3
100
BUY
192.88
100
BUY
202946.1
100
SELL
202946.1
100
SELL
70944.79
100
BUY
10713557.1
100
BUY
70944.79
100
SELL
10713557.1
100
SELL
232993.53
100
BUY
232993.53
100
SELL
3007.5
100
BUY
3007.5
100
BUY
4825.07
100
SELL
4825.07
100
SELL
3127.8
100
BUY
3127.8
100
BUY
5018.07
100
SELL
5018.07
100
BUY
138982
100
SELL
69587.92
100
BUY
61640.55
100
SELL
138982
100
BUY
69587.92
100
SELL
62997.42
100
BUY
62997.42
100
SELL
360.9
100
BUY
721.8
100
SELL
721.8
100
BUY
1323.3
100
BUY
38379.97
100
SELL
81799.72
100
BUY
81799.72
100
SELL
1323.3
100
SELL
78504.48
100
BUY
360.9
100
BUY
78504.48
100
SELL
35860.07
100
BUY
35860.07
100
BUY
16863.93
100
SELL
352591.72
100
BUY
352591.72
100
SELL
35472.38
100
BUY
35472.38
100
SELL
16863.93
100
BUY
7379614.72
100
SELL
104672.64
100
BUY
104672.64
100
BUY
2123.03
100
SELL
2123.03
100
BUY
48265.72
100
SELL
91879.32
100
BUY
171159.15
100
SELL
495644.32
100
SELL
171159.15
100
BUY
495644.32
100
SELL
119404.32
100
BUY
130645.8
100
BUY
119404.32
100
SELL
100602.04
100
BUY
100602.04
100
SELL
130645.8
100
SELL
101377.39
100
BUY
101377.39
100
BUY
91879.32
100
SELL
176586.62
100
BUY
176586.62
100
SELL
7379614.72
100
BUY
141695.74
100
SELL
106224.9
100
SELL
4825.07
100
SELL
141695.74
100
BUY
106224.9
100
BUY
4825.07
100
BUY
58151.46
100
SELL
58151.46
100
BUY
1351.02
100
BUY
4878907.89
100
SELL
1351.02
100
SELL
4878907.89
100
BUY
111456.98
100
BUY
3007.5
100
SELL
111456.98
100
SELL
3007.5
100
BUY
1544.02
100
SELL
1544.02
100
SELL
61640.55
100
SELL
27019.65
100
BUY
27019.65
100
SELL
210508.3
100
SELL
2333.1
100
BUY
2333.1
100
BUY
210508.3
100
BUY
964.86
100
SELL
964.86
100
BUY
58926.82
100
BUY
976750.77
100
SELL
58926.82
100
BUY
386
100
SELL
386
100
SELL
38767.63
100
BUY
3271601.42
100
SELL
64741.97
100
BUY
38767.63
100
SELL
41287.54
100
BUY
64741.97
100
SELL
38379.97
100
BUY
41287.54
100
SELL
3271601.42
100
BUY
32034.39
100
SELL
32034.39
100
BUY
12543.58
100
SELL
12543.58
100
SELL
569884.35
100
BUY
569884.35
100
SELL
3127.8
100
BUY
2175.6
100
BUY
3127.8
100
SELL
2175.6
100
SELL
360.9
100
BUY
5018.07
100
BUY
360.9
100
SELL
5018.07
100
BUY
35860.07
100
SELL
21615.72
100
BUY
21615.72
100
SELL
976750.77
100
SELL
35860.07
100
BUY
13473.6
100
SELL
13473.6
100
(b) Derivatives transactions (other than options transactions)
Product name,
e.g. CFD
Nature of transaction
(Note 6)
Number of relevant securities
(Note 7)
Price per unit
(Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name,
e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise price
Type, e.g. American, European etc.
Expiry date
Option money paid/received per unit (Note 5)
(ii) Exercising
Product name,
e.g. call option
Number of securities
Exercise price per unit (Note 5)
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction
(Note 8)
Details
Price per unit
(if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure
13th May 2020
Contact name
Goeffrey Doggart
Telephone number
2079821783
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDISESFAFEDESSEDI
Recent news on Abbvie
See all newsRCS - Ripple Therapeutics - Ripple Therapeutics Announces Collaboration
AnnouncementREG - Stock Exch Notice - Admission to ISM - 20/06/2024
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
Announcement